drug
as of 2026-07-01Duloxetine
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Central Institute of Mental Health, Mannheim
2 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Trials
2
Pharmacovigilance in Gerontopsychiatric Patients
NCT02374567Phase 3Terminated
Treatment of MDEs During the Course of Psychotic Disorders With Duloxetine
NCT00224302Phase 4Completed
KOLs & investigators
2
Mathias Zink, MDKOL score 6
Helge Frieling, Prof., MDKOL score 5
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication
KOL
Mathias Zink, MD
personKOL score 6
Helge Frieling, Prof., MD
personKOL score 5